Table 2.
Acute coronary syndromes |
Chronic coronary syndromes |
Pa | |||||||
---|---|---|---|---|---|---|---|---|---|
All, N = 673 (809 lesions) | Supreme DES, n = 441 (532 lesions) | DP-EES, n = 232 (277 lesions) | P | All, N = 955 (1136 lesions) | Supreme DES, n = 645 (751 lesions) | DP-EES n = 310 (385 lesions) | P | ||
Stent implantation characteristics | |||||||||
No. of stents per lesion | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | .92 | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.0 ± 0.2 | .12 | .43 |
Stented lesion length, mm | 22.26 ± 9.43 | 22.57 ± 9.65 | 21.66 ± 8.99 | .12 | 22.14 ± 8.51 | 22.30 ± 8.67 | 21.81 ± 8.19 | .22 | .62 |
Maximum stent diameter, mm | 2.97 ± 0.43 | 2.95 ± 0.42 | 3.00 ± 0.44 | .24 | 2.91 ± 0.41 | 2.91 ± 0.41 | 2.91 ± 0.42 | .61 | .004 |
Procedural characteristics | |||||||||
Fractional flow reserve | 3.6% (30) | 3.7% (20) | 3.5% (10) | .88 | 10.6% (123) | 10.2% (78) | 11.5% (45) | .49 | <.0001 |
Intravascular ultrasound | 8.4% (69) | 8.9% (48) | 7.3% (21) | .44 | 20.0% (231) | 19.9% (152) | 20.2% (79) | .89 | <.0001 |
Predilation | 76.4% (630) | 79.6% (429) | 70.3% (201) | .03 | 75.9% (887) | 77.5% (593) | 72.6% (284) | .07 | .80 |
Postdilation | 53.6% (440) | 53.2% (285) | 54.4% (155) | .74 | 51.5% (591) | 51.7% (393/760) | 51.0% (198/388) | .83 | .35 |
Target vessel locationb | |||||||||
Left anterior descending | 43.3% (350) | 44.5% (237) | 40.8% (113) | .18 | 46.0% (522) | 45.9% (345) | 46.0% (177) | .94 | .24 |
Left circumflex | 26.6% (215) | 27.1% (144) | 25.6% (71) | .96 | 24.4% (227) | 25.3% (190) | 22.6% (87) | .38 | .28 |
Right coronary | 30.2% (244) | 28.4% (151) | 33.6% (93) | .13 | 29.6% (236) | 28.6% (215) | 31.4% (121) | .34 | .77 |
Left main | 0.0% (0) | 0.0% (0) | 0.0% (0) | NA | 0.1% (1) | 0.1% (1) | 0.0% (0) | 1.0 | .98 |
ACC/AHA lesion class | |||||||||
A | 9.4% (76) | 8.6% (46) | 10.8% (30) | .33 | 7.7% (88) | 7.1% (53) | 9.1% (35) | .23 | .20 |
B1 | 26.3% (213) | 24.4% (130) | 30.0% (83) | .11 | 24.5% (278) | 25.8% (194) | 21.8% (84) | .14 | .37 |
B2 | 26.1% (211) | 27.3% (145) | 23.8% (66) | .30 | 28.2% (320) | 26.2% (197) | 31.9% (123) | .05 | .32 |
C | 38.2% (309) | 39.7% (211) | 35.4% (98) | .28 | 39.6% (450) | 40.9% (307) | 37.1% (143) | .24 | .53 |
B2/C | 64.3% (520) | 66.9% (356) | 59.2% (164) | .04 | 67.8% (770) | 67.1% (504) | 69.1% (266) | .50 | .12 |
Calcification (moderate/severe) | 30.9% (249/807) | 31.7% (168/530) | 29.2% (81) | .56 | 36.5% (415) | 37.0% (278) | 35.6% (137) | .77 | .014 |
Any bifurcation | 21.1% (171) | 21.4% (114) | 29.6% (57) | .78 | 22.3% (253) | 22.4% (168) | 22.1% (85) | .94 | .55 |
Baseline QCA resultsb | |||||||||
Reference diameter, mm | 2.74 ± 0.45 | 2.72 ± 0.44 | 2.77 ± 0.47 | .10 | 2.68 ± 0.48 | 2.69 ± 0.48 | 2.67 ± 0.47 | .47 | .01 |
Minimal lumen diameter, mm | 0.87 ± 0.38 | 0.85 ± 0.37 | 0.90 ± 0.40 | .07 | 0.97 ± 0.39 | 0.98 ± 0.40 | 0.96 ± 0.39 | .40 | <.0001 |
Percent diameter stenosis, % | 68.02 ± 13.04 | 68.35 ± 12.97 | 67.37 ± 13.16 | .31 | 63.63 ± 13.19 | 63.49 ± 13.19 | 63.92 ± 13.20 | .68 | <.0001 |
Lesion length, mmc | 15.22 ± 7.73 | 15.53 ± 8.16 | 14.64 ± 6.83 | .16 | 15.06 ± 7.13 | 15.11 ± 7.10 | 14.95 ± 7.20 | .73 | .63 |
Final QCA resultb | |||||||||
In-stent minimal lumen diameter, mmc | 2.70 ± 0.40 | 2.68 ± 0.40 | 2.73 ± 0.40 | .09 | 2.65 ± 0.40 | 2.65 ± 0.41 | 2.65 ± 0.38 | .96 | .012 |
In-stent diameter stenosis, %c | 7.99 ± 4.72 | 8.14 ± 4.97 | 7.70 ± 4.22 | .20 | 8.38 ± 4.58 | 8.50 ± 4.34 | 8.14 ± 5.01 | .21 | .07 |
In-stent acute gain, mmc | 1.83 ± 0.46 | 1.83 ± 0.46 | 1.83 ± 0.47 | .92 | 1.68 ± 0.45 | 1.67 ± 0.45 | 1.69 ± 0.44 | .56 | <.0001 |
Segment minimal lumen diameter, mmd | 2.59 ± 0.41 | 2.57 ± 0.40 | 2.64 ± 0.41 | .03 | 2.55 ± 0.43 | 2.55 ± 0.43 | 2.54 ± 0.42 | .74 | .02 |
Segment diameter stenosis, %d | 9.65 ± 3.86 | 9.70 ± 3.89 | 9.55 ± 3.81 | .66 | 10.06 ± 4.80 | 10.09 ± 4.86 | 10.00 ± 4.68 | .75 | .06 |
Segment acute gain, mmd | 1.72 ± 0.47 | 1.72 ± 0.48 | 1.73 ± 0.47 | .69 | 1.57 ± 0.46 | 1.57 ± 0.46 | 1.58 ± 0.46 | .82 | <.0001 |
Values are given as mean ± standard deviation or % (n).
ACC, American College of Cardiology; AHA, American Heart Association; QCA, quantitative coronary angiography.
All patients with acute coronary syndromes (ACS) vs all patients with chronic coronary syndromes (CCS) regardless of stent.
The results reported based on the angiographic core laboratory analysis.
The total number of lesions was 802 for ACS and 1120 for CCS.
The total number of lesions was 804 for ACS and 1127 for CCS.